Ibex Medical Analytics is a company founded in Tel Aviv, Israel, in 2016. The main focus of Ibex is to provide AI-based analytic solutions for cancer diagnostics. The company has developed a platform called Galen, which assists with diagnosis, planning, and treatment.(1)
AIdoc is another company founded in Tel Aviv, Israel, in 2016. This company developed a single-screen system platform for radiologists that streamlines medical imaging by creating a unique, user-friendly, intelligent display. This system improves radiologists’ workflow while diagnosing scans and improving accuracy.(2)
MeMed is a company founded in Tirat Karmel, Israel, in 2009. It provides machine learning-based diagnostic solutions for infectious diseases. The company released a lead product called ImmunoXpert, which distinguishes between bacterial and viral infections based on the patient’s immune response using an in vitro diagnostic test. The company also offers another device called ImmunoPoc, which distinguishes between bacterial and viral infections at the point of care.(3)
MeMed is a company founded in Tirat Karmel, Israel, in 2009. It provides machine learning-based diagnostic solutions for infectious diseases. The company released a lead product called ImmunoXpert, which distinguishes between bacterial and viral infections based on the patient’s immune response using an in vitro diagnostic test.
The company also offers another device called ImmunoPoc, which distinguishes between bacterial and viral infections at the point of care.(3)
OrCam is a company founded in Jerusalem, Israel, in 2010. The company developed a wearable device that assists blind, visually impaired individuals or those with other disabilities, such as reading. Two products that the company developed are MyEye and MyReader. MyEye is a camera that can be attached to the frame of a pair of glasses via a magnet. MyReader is another product that allows users to read any text, on any surface, including newspapers, books, and computer screens.(4)
OrCam is a company founded in Jerusalem, Israel, in 2010. The company developed a wearable device that assists blind, visually impaired individuals or those with other disabilities, such as reading. Two products that the company developed are MyEye and MyReader.
MyEye is a camera that can be attached to the frame of a pair of glasses via a magnet. MyReader is another product that allows users to read any text, on any surface, including newspapers, books, and computer screens.(4)
Sight diagnostics is a company founded in Jerusalem, Israel, in 2011. This company developed a platform for blood analysis and infectious disease diagnostics. The first product that this company developed is called the Parasight malaria detection platform, which helps identify and detect malaria species.(5)
Intuition robotics is a company in Tel Aviv, Israel, founded in 2015. The company has developed a social robot that provides companionship, aid, and entertainment to the elderly. The robot employs cognitive computing, NLP, computer vision, and emotion detection to communicate with adults through voice commands and video chat. Additionally, the robot enables proactive commands and entertains the user.(6)
Intuition robotics is a company in Tel Aviv, Israel, founded in 2015. The company has developed a social robot that provides companionship, aid, and entertainment to the elderly.
The robot employs cognitive computing, NLP, computer vision, and emotion detection to communicate with adults through voice commands and video chat. Additionally, the robot enables proactive commands and entertains the user.(6)
Medial Earlysign is a company founded in Kfar Saba, Israel, in 2009. This company developed a machine learning-based decision support tool that enables the interpretation of personal and outcome-based medical data. The AI-powered tool provides individualized predictions and treatment options for the patient. It is also thought to aid in the early recognition of life-threatening conditions. The first commercial use of this company focused on the early prognosis of colorectal cancer.(7)